3rd-Feb-2012 17:45Source: BSE

Glenmark- Limited Review for Dec 31, 2011

Glenmark Pharmaceuticals Ltd has submitted to BSE a Copy of the Limited Review Report for the period ended December 31, 2011.

31st-Jan-2012 09:57Source: NSE

Glenmark Pharmaceuticals Limited

Glenmark Pharmaceuticals Limited has informed the Exchange that at the meeting of the Board of Directors held on January 30, 2012, Dr. Brian W. Tempest and Mr. Bernard Munos have been appointed as Add...

30th-Jan-2012 16:30Source: BSE

Glenmark- Outcome of Board Meeting

Glenmark Pharmaceuticals Ltd has informed BSE that at the meeting of the Board of Directors held on January 30, 2012, Dr. Brian W. Tempest and Mr. Bernard Munos have been appointed as Additional Direc...

30th-Jan-2012 16:25Source: NSE

Glenmark Pharmaceuticals Limited-Consolidated Result Updates - IFRS

Glenmark Pharmaceuticals Limited has submitted to the Exchange a copy of Un-Audited Consolidated Financial Results of the Company and its subsidiaries for the quarter and nine months ended December 31...

30th-Jan-2012 16:20Source: NSE

Glenmark Pharmaceuticals Limited

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 30, 2012, titled "Glenmark''s consolidated revenue increases by 37.73% to Rs. 10,310.86 mn for Q3 FY ...

30th-Jan-2012 16:18Source: NSE

Glenmark Pharmaceuticals Limited

Glenmark Pharmaceuticals Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2011 as follows: Net Sales of Rs. 39688 lacs for quarter ending on 31-DEC-20...

30th-Jan-2012 16:17Source: NSE

Glenmark Pharmaceuticals Limited

Glenmark Pharmaceuticals Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended December 31,2011.

30th-Jan-2012 15:55Source: BSE

Glenmark- Announces Q3 Results & Results Press Release for the quarter ended on Dec 31, 2011

Glenmark Pharmaceuticals Ltd has announced the following results for the quarter ended December 31, 2011:

The Unaudited results for the Quarter ended December 31, 2011

The Company has po...

20th-Jan-2012 13:16Source: BSE

Glenmark- Q3 results on Jan 30, 2012

Glenmark Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on January 30, 2012, to consider and approve the Un-Audited Financial Results for the...

20th-Jan-2012 09:44Source: BSE

Glenmark- Glenmark Generics received Two Oral Contraceptives product approval from the USFDA

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated January 20, 2012 titled "Glenmark Generics received Two Oral Contraceptives product approval from the USFDA"